Statin and P2Y12 platelet inhibitor combination

This page covers all Statin and P2Y12 platelet inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HMG-CoA reductase and P2Y12 receptor.

Targets

HMG-CoA reductase and P2Y12 receptor

Marketed (1)

• atorvastatin and clopidogrel · Ospedale Misericordia e Dolce · Cardiovascular
  This combination reduces cholesterol levels and prevents blood clots by inhibiting HMG-CoA reductase and platelet aggregation, respectively.

Patent intelligence

• statin and p2y12 platelet inhibitor combination patent landscape — aggregated cliff calendar, attackable patents, originator estates